Inflammatory Breast Cancer - 25 Studies Found

Active, not recruiting : Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
: Breast Cancer
: 2009-01-09
:
  • Biological: bevacizumab During
Recruiting : Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC)
: Breast Cancer
: 2015-03-10
:
  • Drug: BIBF 1120 Initial dose i
Completed : MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
: Breast Cancer
: 2015-04-03
:
  • Drug: MK-3475 200 mg administe
Active, not recruiting : Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
: Breast Cancer
: 2009-12-17
:
  • Drug: Panitumumab 2.5 mg/kg IV
Completed : Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
: Breast Cancer
: 2001-05-16
: Biological: Bevacizumab
<<< Previous